Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...

Health-care companies fell as traders weighed risks in a wave of deal activity. Pfizer joined Big Pharma rivals hunting for novel weight loss drugs in the Chinese biotech sector.

Jeff Williams, a former Apple executive who retired from the tech giant earlier this year, will stand for election as a new ...

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply ...

Disney has nominated former Apple chief operating officer Jeff Williams to stand election as a new independent board director at the media giant's 2026 annual meeting of shareholders. If elected, ...

Companies like Cigna and CVS are promising simpler prices, but the behind-the-scenes system remains complex.

The Florida Gators have a new football coach but that coach, Jon Sumrall, is still coaching Tulane, which plays North Texas Friday night.

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

The panel will work with a national firm to hire a successor to Thorr Bjorn, who will depart at the end of November after 18 years in Kingston.

Welcome The Hill’s annual list of Top Lobbyists. President Trump’s return to the White House brought a whirlwind of policy ...

The world’s largest drugmaker, Eli Lilly & Co., just notched another milestone: it’s the first health-care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s ...